Global Carpal Tunnel Release System Market - 2023-2030

Overview

Carpal tunnel release system is a medical procedure and a set of techniques that are used to treat carpal tunnel syndrome (CTS). CTS is a frequently occurring condition in which the median nerve, running from the forearm into the hand, gets compressed or squeezed as it passes through a narrow passageway called the carpal tunnel in the wrist.

There are two main surgical approaches used to treat carpal tunnel syndrome (CTS) open carpal tunnel release system and endoscopic carpal tunnel release system. Furthermore, the increasing prevalence of carpal tunnel syndrome, new approaches to carpal tunnel release and treatment of tendinopathy, and rising medical education training programs by the market players are the factors expected to drive the market over the forecast period.

Dynamics

New Approaches to Carpal Tunnel Release and Treatment of Tendinopathy is Expected to Drive Market Growth

Patients with carpal tunnel syndrome often experience tendinopathy, a common condition. Carpal tunnel release systems have recently been improved to address tendinopathy in addition to releasing the carpal tunnel. For instance, the Mayo Clinic is one of the few hand centers that provide ultrasound-guided intervention for carpal tunnel release, which is an advanced treatment. Thread Ultrasound-Guided Carpal Tunnel Release (TCTR) is a newer, minimally invasive technique that does not require large incisions. Compared to traditional open CTR procedures, this approach significantly reduces the damage to the surrounding tissues, resulting in less postoperative pain and faster recovery times for patients.

The use of ultrasound guidance is a crucial aspect of TCTR. This technology enables surgeons to view the internal structures of the carpal tunnel in real time, ensuring accurate and precise placement of the abrasive thread. As a result, the risk of harm to surrounding structures is reduced, and the procedure becomes more effective and safe.

In addition, TCTR is usually done on an outpatient basis, allowing patients to return home on the same day of the operation. This not only increases patient convenience but also results in reduced healthcare expenses. TCTR is a less invasive alternative to traditional CTR, which means that recovery times may be faster for patients. This can enable many individuals to resume their daily activities earlier and potentially require less postoperative rehabilitation.

Therefore, the procedure becomes more widespread and refined, it may influence research and innovation in carpal tunnel release, leading to further improvements in techniques and technologies. Thus, owing to the above factors, the market is expected to drive over the forecast period.

High Cost of Carpal Tunnel Release System is Expected to Hamper the Market Growth

The cost of carpal tunnel release systems, especially minimally invasive ones like the Microaire 81014, is very high around $2,500. This high cost poses a significant problem for both patients and healthcare facilities. Many patients are deterred from seeking treatment for carpal tunnel syndrome due to the high cost, which can lead to prolonged pain and disability.

Additionally, healthcare facilities in regions with limited budgets may not be able to afford these expensive systems, which limits access to advanced carpal tunnel release techniques. Therefore, the high costs associated with these systems have led to reduced market penetration and hindered their widespread adoption, ultimately impacting patient care and healthcare infrastructure in affected regions.

Segment Analysis

The global carpal tunnel release system market is segmented based on product type, surgical approach, technology, end-user and region.

The Endoscopic Carpal Tunnel Release Systems from the Product Type Segment Accounted for Approximately 56.3% of the Carpal Tunnel Release System Market Share

Carpal tunnel syndrome is a common condition where the median nerve in the wrist is compressed and causes discomfort. Endoscopic Carpal Tunnel Release Systems (ECTRS) are minimally invasive surgical tools designed to treat this condition. ECTRS involves the use of a small endoscope, which is a thin tube with a camera, and specialized instruments to release the transverse carpal ligament. This procedure helps to alleviate the pressure on the median nerve and provides relief from the symptoms of carpal tunnel syndrome.

Moreover, it leads to smaller incisions, reduced post-operative pain, faster recovery times, and less scarring when compared to traditional open surgery. ECTRS also enables patients to return to their daily activities and work more quickly, making it a more appealing choice for those searching for a faster and less disruptive remedy for carpal tunnel syndrome.

In addition, ECTRS enables patients to return to their daily activities and work sooner, making it an attractive option for individuals seeking a faster and less disruptive treatment for carpal tunnel syndrome. Furthermore, increasing preference for minimally invasive procedures, increasing the prevalence of carpal tunnel syndrome, and technological advancements are the factors expected to drive the market segment over the forecast period.

For instance, the traditional method for treating this condition involved open surgery, which required a larger incision in the wrist to access and release the compressed median nerve. However, with the advancement of minimally invasive techniques, endoscopic carpal tunnel release has become more popular.

The Endotrac Endoscopic Carpal Tunnel Release System by Stryker is a medical device that enables minimally invasive surgical treatment of carpal tunnel syndrome, a common condition where the median nerve in the wrist is compressed.

Therefore, endoscopic carpal tunnel release systems have gained more popularity among patients and healthcare providers as compared to traditional open surgery in treating carpal tunnel syndrome. This trend reflects the broader shift in medicine toward minimally invasive procedures whenever feasible, as they tend to offer better patient outcomes and experiences. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Penetration

North America Accounted for Approximately 39.2% of the Market Share in 2022

North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of carpal tunnel syndrome, increasing adoption of surgical intervention, the introduction of new products, and rising healthcare expenditure.

For instance, according to the Mayo Foundation for Medical Education and Research (MFMER) Article, Carpal tunnel syndrome is a common condition that affects many people, and it is estimated that 71% of patients undergo surgical intervention as their primary treatment.

The cost of medical care for carpal tunnel syndrome in the United States is approximately $2 billion per year, and the median time lost from work is just under 30 days. The surgical treatment usually involves an open procedure, while the endoscopic approach is often associated with less postoperative pain and a faster return to work.

Competitive Landscape

The major global players in the carpal tunnel release system market include: Arthrex, Inc., MicroAire Surgical Instruments, LLC, Trice Medical, Smith & Nephew plc, Integra LifeSciences Corporation, Stryker Corporation, Innomed, Inc., A.M. Surgical, Inc., Medical Designs, LLC, and Sonex Health Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has negatively impacted the carpal tunnel release system market. Due to the COVID-19 pandemic, healthcare facilities have been focusing their resources on treating infected patients while trying to limit the spread of the virus. As a result, many elective surgeries, such as carpal tunnel release procedures, have been postponed or canceled. This temporary delay in surgeries has caused a decline in demand for carpal tunnel release systems.

The pandemic has caused a prominent rise in remote consultations and telemedicine. Therefore, some patients with mild to moderate carpal tunnel syndrome might have chosen non-surgical treatments and remote consultations instead of surgery, which could have impacted the demand for carpal tunnel release systems. The pandemic has also highlighted the significance of safety in healthcare settings. This focus on safety may have accelerated the adoption of minimally invasive techniques such as endoscopic carpal tunnel release systems, which provide advantages such as reduced hospital stays and faster recovery times.

By Product Type

• Open Carpal Tunnel Release Systems
• Endoscopic Carpal Tunnel Release Systems

By Surgical Approach

• Minimally Invasive
• Open Surgery

By End User

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• On August 9, 2022, Sonex Health and The Institute of Advanced Ultrasound Guided Procedures enrolled first patient in the trial of ultrasound guided Carpal Tunnel Release (CTR) versus Traditional Open Release (TUTOR) the first multicenter randomized controlled trial in the United States to compare the efficacy and safety of traditional mini-open carpal tunnel release (mOCTR) and carpal tunnel release using the FDA-cleared UltraGuideCTR and real-time ultrasound guidance.

Why Purchase the Report?

• To visualize the global carpal tunnel release system market segmentation based on product type, surgical approach, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of carpal tunnel release system market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global carpal tunnel release system market report would provide approximately 61 tables, 56 figures, and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies